Following encouraging clinical data , retatrutide, a novel peptide therapy for treating adult-onset diabetes , has received regulatory approval from Great Britain's Medicines and Regulatory Agency ( MHRA https://shopretatrutidepeptide.com/category/retatrutide-peptide/